Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitously expressed transcript protein (UXT), also known as androgen receptor trapped clone 27 protein (ART-27), is a prefoldin-like protein encoded by the UXT gene on chromosome Xp11.23. It functions mainly as a transcriptional co-regulator, interacting with the N-terminus of the androgen receptor (AR) and modulating AR-dependent transcription. UXT/ART-27 acts largely as a corepressor of the AR, suppressing the transcription of genes involved in cell proliferation. It is highly expressed in various normal and tumor tissues, including prostate and breast, and its reduced expression is linked to prostate cancer progression. UXT is also a centrosomal protein critical for centrosome organization and cell viability; its overexpression disrupts centrosome structure and may promote tumorigenesis. Although it plays essential roles in several cellular processes and diseases, it is not currently characterized as a direct therapeutic drug target, enzyme, transporter, or classical receptor[1][2][3][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitously expressed transcript protein (UXT).